BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Down 77.2% in August

BetterLife Pharma Inc. (OTCMKTS:BETRF) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decrease of 77.2% from the July 31st total of 5,700 shares. Based on an average daily volume of 16,300 shares, the short-interest ratio is presently 0.1 days.

BetterLife Pharma Price Performance

Shares of BetterLife Pharma stock opened at $0.11 on Wednesday. The company has a market cap of $13.46 million, a price-to-earnings ratio of -3.67 and a beta of 1.24. The company’s 50 day moving average is $0.10 and its 200 day moving average is $0.09. BetterLife Pharma has a twelve month low of $0.03 and a twelve month high of $0.15.

BetterLife Pharma (OTCMKTS:BETRF) last released its quarterly earnings results on Thursday, June 27th. The company reported ($0.01) earnings per share for the quarter.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.